NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/19/2026
Back to search
Official data from USPTO
LUMINA PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
05/19/2026
Trademark type
Combined
Nice classes
5
Filing date
04/18/2025
Registration date
05/19/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/19/2026
Last transaction
05/19/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
05/16/2024
First use in commerce
05/16/2024
Drawing code
3
Owner type
03
Owner location
Wilmington, DE, US
Examiner
SNYDER, NELSON B
Law office
L70
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of a stylized human figure with a circle forming the head and two wavy lines forming arms and a portion of the body. The uppermost end of a wavy line arm is pointing to a cluster of small stars arranged in a diamond-shaped pattern. The stylized wording "LUMINA PHARMACEUTICALS" appears to the right of the star designs, with "LUMINA" appearing in larger type above "PHARMACEUTICALS".
Holders and representatives
Holders
Lumina Pharmaceuticals Inc.
Representatives
Megan E. Fink Bodman PLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Radioactive pharmaceutical preparations for exclusive use in vivo diagnostic or therapeutic usenone of the foregoing being substances injected for dermal use or substances affecting metabolism or related to medical wound dressings or for use in the treatment of immunological or dermatological diseases or disorders
Publications
History of USPTO decisions and trademark events.
29 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/19/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/31/2026
PUBO
PUBLISHED FOR OPPOSITION
03/31/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/25/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/10/2026
XAEC
EXAMINER'S AMENDMENT ENTERED
03/10/2026
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/10/2026
GNEA
EXAMINERS AMENDMENT E-MAILED
03/10/2026
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/10/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/09/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/09/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/09/2026
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
03/09/2026
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
03/09/2026
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/09/2026
GNRT
NON-FINAL ACTION E-MAILED
01/09/2026
CNRT
NON-FINAL ACTION WRITTEN
01/09/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/12/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/12/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/12/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/19/2025
GNRT
NON-FINAL ACTION E-MAILED
09/19/2025
CNRT
NON-FINAL ACTION WRITTEN
09/19/2025
DOCK
ASSIGNED TO EXAMINER
09/12/2025
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
08/26/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/26/2025
MAFR
APPLICATION FILING RECEIPT MAILED
04/18/2025
NWAP
NEW APPLICATION ENTERED
04/18/2025
Continuous trademark protection
Get notified about every new filing that threatens LUMINA PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.